Our company’s technological focus is on developing a peptide-tagged PEGylated chitosan nanoparticles, which enables siRNA delivery to the targeted site via non-invasive routes of administration. We focus ...
Nanorapharma USA is a pharmaceutical company that is involved in developing a polymeric nano-delivery vehicle for therapeutics like small interfering RNA (siRNA), pDNA (plasmid DNA), shRNA (short hair-pin ...
